Fibrinogen and cardiovascular risk
- PMID: 9546953
- DOI: 10.1177/1358863X9700200207
Fibrinogen and cardiovascular risk
Abstract
The hypothesis that fibrinogen is closely related to cardiovascular risk has been strengthened through the results of various lines of research, which this review will aim to unravel. Several prospective epidemiological studies convincingly show elevated fibrinogen to represent a major, independent cardiovascular risk factor. Cross-sectional studies strongly associate fibrinogen and conventional cardiovascular risk factors. Clinical cohort studies demonstrate that increased fibrinogen is also a risk factor for the sequelae of cardiovascular disease. Our knowledge about the determinants of the variable plasma level of fibrinogen in health and disease is incomplete. Understanding of the mechanisms that might be involved in the atherothrombogenic action of fibrinogen is also fragmentary. Fibrinogen strongly affects blood coagulation, blood rheology and platelet aggregation. In addition, it has direct effects on the vascular wall and is a prominent acute phase reactant. All of these phenomena might constitute pathophysiological mechanisms involved in the association between fibrinogen and cardiovascular events. Their relative importance is unclear at present. Even though many crucial questions await conclusive answers, little doubt exists that fibrinogen represents a major, independent risk factor.
Similar articles
-
Fibrinogen: its emerging role as a cardiovascular risk factor.Angiology. 1994 Feb;45(2):87-93. doi: 10.1177/000331979404500201. Angiology. 1994. PMID: 8129195 Review.
-
The role of fibrinogen as a cardiovascular risk factor.Atherosclerosis. 1993 Apr;100(1):1-12. doi: 10.1016/0021-9150(93)90062-y. Atherosclerosis. 1993. PMID: 8318054 Review.
-
Fibrinogen: an important risk factor for atherothrombotic diseases.Ann Med. 1994 Feb;26(1):15-22. doi: 10.3109/07853899409147322. Ann Med. 1994. PMID: 8166985 Review.
-
[Fibrinogen. Cardiovascular risk factor or marker?].Arch Cardiol Mex. 2006 Oct-Dec;76 Suppl 4:S158-72. Arch Cardiol Mex. 2006. PMID: 17469344 Review. Spanish.
-
Fibrinogen as a cardiovascular risk factor--interrelationship with infections and inflammation.Eur Heart J. 1993 Dec;14 Suppl K:82-7. Eur Heart J. 1993. PMID: 8131795 Review.
Cited by
-
Vascular endothelial growth factor and monocyte chemoattractant protein-1 levels unaltered in symptomatic atherosclerotic carotid plaque patients from north India.Front Neurol. 2013 Apr 2;4:27. doi: 10.3389/fneur.2013.00027. eCollection 2013. Front Neurol. 2013. PMID: 23565106 Free PMC article.
-
Exercise and training effects on blood haemostasis in health and disease: an update.Sports Med. 2004;34(3):181-200. doi: 10.2165/00007256-200434030-00004. Sports Med. 2004. PMID: 14987127 Review.
-
Assessment of subclinical atherosclerosis and cardiovascular risk.Clin Cardiol. 2001 Oct;24(10):642-50. doi: 10.1002/clc.4960241003. Clin Cardiol. 2001. PMID: 11594409 Free PMC article. Review.
-
Levels of serum IL-1beta, IL-2, IL-8 and tumor necrosis factor-alpha in patients with unstable angina pectoris.Mediators Inflamm. 2003 Dec;12(6):361-5. doi: 10.1080/09629350310001633360. Mediators Inflamm. 2003. PMID: 14668096 Free PMC article.
-
Serum Inflammatory and Prooxidant Marker Levels in Different Periodontal Disease Stages.Healthcare (Basel). 2021 Aug 20;9(8):1070. doi: 10.3390/healthcare9081070. Healthcare (Basel). 2021. PMID: 34442206 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
